Skip to main content


Page 1 of 33

  1. Ovarian cancer (OV) is a highly fatal malignant disease that commonly manifests at an advanced stage. Drug resistance, particularly platinum resistance, is a leading cause of treatment failure because first-li...

    Authors: Xiao Li, Zhen Zheng, Wanzhen Zhou, Huixian Huang, Yang Zhou, Qinyang Xu, Xiaolu Zhu and Yincheng Teng
    Citation: Journal of Ovarian Research 2024 17:124
  2. Endometriosis is a heritable, complex chronic inflammatory disease, for which much of the causal pathogenic mechanism remain unknown.Despite the high prevalence of ovarian chocolate cyst, its origin is still u...

    Authors: Xiaohui Zhang, Xiaojing Zhao, Jiapo Wang, Yifang Zhang and Jinhong Chen
    Citation: Journal of Ovarian Research 2024 17:122
  3. Polycystic Ovary Syndrome (PCOS) is a widespread endocrine disorder among women, characterized by symptoms like ovarian cysts, hormonal imbalance, and metabolic issues. This research evaluates the therapeutic ...

    Authors: Xiaojing Teng, Zhiyi Wang and Xiaolei Wang
    Citation: Journal of Ovarian Research 2024 17:121
  4. The common marmoset, Callithrix jacchus, is an invaluable model in biomedical research. Its use includes genetic engineering applications, which require manipulations of oocytes and production of embryos in vitro...

    Authors: Olena Y. Tkachenko, Tobias Kahland, Dimitri Lindenwald, Michael Heistermann, Charis Drummer, Maria Daskalaki, Nancy Rüger and Rüdiger Behr
    Citation: Journal of Ovarian Research 2024 17:120
  5. Ovarian clear cell carcinoma (OCCC) is a rare pathological histotype in ovarian cancer, while the survival rate of advanced OCCC (Stage III-IV) is substantially lower than that of the advanced serous ovarian c...

    Authors: Tingwei Liu, Yueqing Gao, Shuangdi Li and Shaohua Xu
    Citation: Journal of Ovarian Research 2024 17:119
  6. In women who are getting older, the quantity and quality of their follicles or oocytes and decline. This is characterized by decreased ovarian reserve function (DOR), fewer remaining oocytes, and lower quality...

    Authors: Shenglan Bao, Tailang Yin and Su Liu
    Citation: Journal of Ovarian Research 2024 17:118
  7. The 2016 Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria redefined the poor responders as low prognosis patients. The embryo transfer strategy for POSEIDON patients rema...

    Authors: Rang Liu, Qiuju Zhang, Lan Geng, Huiqing He, Chang Xu, Jiali Feng, Miaoling Song, Yanpei Cao, Tianren Wang and Xi Xia
    Citation: Journal of Ovarian Research 2024 17:117
  8. PCOS patients with unexpectedly low oocyte yield following conventional ovarian stimulation are referred to as suboptimal responders. However, identifying suboptimal responders presents a significant challenge...

    Authors: Xiaohang Xu, Yilin Jiang, Jinlin Du, Haoyue Sun, Xue Wang and Cuilian Zhang
    Citation: Journal of Ovarian Research 2024 17:116
  9. Zinc (Zn) is a crucial trace element essential for human growth and development, particularly for reproductive health. Previous research has shown a decrease in serum zinc concentration with age and individual...

    Authors: Wen-Jiao Liu, Li-Shu Li, Meng-Fan Lan, Jian-Zhou Shang, Jin-Xin Zhang, Wen-Jie Xiong, Xin-Le Lai and Xing Duan
    Citation: Journal of Ovarian Research 2024 17:115
  10. The key to enhancing the efficacy of antagonistic regimens in pregnancy is to better synchronize follicular growth during cycles of controlled ovarian stimulation (COS), especially in patients with diminished ...

    Authors: Lin Lin, Guoyong Chen and Yun Liu
    Citation: Journal of Ovarian Research 2024 17:114
  11. Ovarian cancer accounts for more deaths than any other female reproductive tract cancer. The major reasons for the high mortality rates include delayed diagnoses and drug resistance. Hence, improved diagnostic...

    Authors: Dhaval Bhavsar, Rajeswari Raguraman, Dongin Kim, Xiaoyu Ren, Anupama Munshi, Kathleen Moore, Vassilios Sikavitsas and Rajagopal Ramesh
    Citation: Journal of Ovarian Research 2024 17:113
  12. Authors: Lu Chen, Wujiang Gao, Li Lin, Chunli Sha, Taoqiong Li, Qi Chen, Hong Wei, Meiling Yang, Jie Xing, Mengxue Zhang, Shijie Zhao, Wenlin Xu, Yuefeng Li, Lulu Long and Xiaolan Zhu
    Citation: Journal of Ovarian Research 2024 17:112

    The original article was published in Journal of Ovarian Research 2023 16:186

  13. This clinical trial was designed and conducted due to the anti-inflammatory potential of Oleoylethanolamide (OEA) to examine the effect of OEA supplement on glycemic status, oxidative stress, inflammatory fact...

    Authors: Fatemeh Taghizadeh Shivyari, Hamideh Pakniat, Mohamadreza Rashidi Nooshabadi, Shaghayegh Rostami, Hossein Khadem Haghighian and Mohammad Reza Shiri-Shahsavari
    Citation: Journal of Ovarian Research 2024 17:111
  14. Recent studies have provided evidence supporting the functional role and mechanism of lactate in suppressing anticancer immunity. However, there is no systematic analysis of lactate metabolism-related genes (L...

    Authors: Jinrui Sun, Qinmei Feng, Yingying Xu, Ping Liu and Yumei Wu
    Citation: Journal of Ovarian Research 2024 17:110
  15. Authors: Ayumu Ito, Yukiko Katagiri, Satoko Oigawa, Kenji Amano, Koichiro Ichizawa, Yukiko Tokuda, Mami Unagami, Masato Yoneyama, Takahiro Tsuchiya, Mami Sekiguchi, Mayuko Furui, Kentaro Nakaoka, Nahomi Umemura, Yuko Hayashi, Yuko Tamaki, Koichi Nagao…
    Citation: Journal of Ovarian Research 2024 17:109

    The original article was published in Journal of Ovarian Research 2023 16:192

  16. Imbalances in alkali elements (AEs) and alkaline earth elements (AEEs) cause reproductive disorders. However, it remains unclear whether AEs/AEEs in follicular fluid have a relationship with the serious reprod...

    Authors: Tian Tian, Qin Li, Fang Liu, Huahua Jiang, Rui Yang, Yue Zhao, Fei Kong, Yuanyuan Wang, Xiaoyu Long and Jie Qiao
    Citation: Journal of Ovarian Research 2024 17:108
  17. Abnormal granulosa cell (GC) death contributes to cyclophosphamide (CTX) induced primary ovarian insufficiency (POI). To investigate the contribution of GCs to POI, gene profiles of GCs exposed to CTX were ass...

    Authors: Hui Chen, Ping Nie, Jingling Li, Yongqi Wu, Bo Yao, Yabing Yang, Gendie E. Lash and Ping Li
    Citation: Journal of Ovarian Research 2024 17:107
  18. Epidemiological studies regarding the correlation between anti-Müllerian hormone (AMH) and insulin resistance (IR) in polycystic ovarian syndrome (PCOS) remain inconsistent. The primary aim of this study was t...

    Authors: Mohd Zakwan Md Muslim, Aniza Mohammed Jelani, Noorazliyana Shafii, Najib Majdi Yaacob, Noor Azlin Azraini Che Soh and Hanim Afzan Ibrahim
    Citation: Journal of Ovarian Research 2024 17:106
  19. In the realm of assisted reproduction, a subset of infertile patients demonstrates high ovarian response following controlled ovarian stimulation (COS), with approximately 29.7% facing the risk of Ovarian Hype...

    Authors: Ling-Ling Ruan, Xing-Yu Lv, Yu-Lin Hu, Ming-Xing Chen, Jing-Tang, Zhao-Hui Zhong, Mei-Hua Bao, Li-Juan Fu, Xin Luo, Shao-Min Yu, Qi Wan and Yu-Bin Ding
    Citation: Journal of Ovarian Research 2024 17:105
  20. The incidence of infertility caused by diminished ovarian reserve has become a significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has already been described, but the high-leve...

    Authors: Máté Éliás, Márton Kónya, Zsófia Kekk, Caner Turan, Isabel Pinto Amorim das Virgens, Réka Tóth, Márton Keszthelyi, Péter Hegyi, Szabolcs Várbíró and Miklós Sipos
    Citation: Journal of Ovarian Research 2024 17:104
  21. Fragile X-associated primary ovarian insufficiency (FXPOI), characterized by amenorrhea before age 40 years, occurs in 20% of female FMR1 premutation carriers. Presently, there are no molecular or biomarkers that...

    Authors: Ines Agusti, Maria Isabel Alvarez-Mora, Robin Wijngaard, Aina Borras, Tamara Barcos, Sara Peralta, Marta Guimera, Anna Goday, Dolors Manau and Laia Rodriguez-Revenga
    Citation: Journal of Ovarian Research 2024 17:103
  22. Ovarian cancer is a major gynecological cancer that has poor prognosis associated mainly to its late diagnosis. Cisplatin is an FDA approved ovarian cancer therapy and even though the therapy is initially prom...

    Authors: Xue-Yan Zhang, Bo-Chi Zhu, Miao He and Shan-Shan Dong
    Citation: Journal of Ovarian Research 2024 17:102
  23. Shikonin (SK), a naphthoquinone with anti-tumor effects, has been found to decrease production of tumor-associated exosomes (exo). This study aims to verify the treatment effect of SK on ovarian cancer (OC) ce...

    Authors: Min Wang, Yangyan Sun, Rui Gu, Yan Tang, Guorong Han and Shaojie Zhao
    Citation: Journal of Ovarian Research 2024 17:101
  24. Polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder with multiple metabolic abnormalities. Most PCOS patients have concomitant metabolic syndromes such as insulin resistance and obesity, whic...

    Authors: Weixuan Chen, Baoying Liao, Chuyu Yun, Min Zhao and Yanli Pang
    Citation: Journal of Ovarian Research 2024 17:100
  25. With increasingly used assisted reproductive technology (ART), the acquisition of high-quality oocytes and early embryos has become the focus of much attention. Studies in mice have found that the transition o...

    Authors: Yi-Ran Zhang, Ying Yin, Shi-Meng Guo, Yu-Fan Wang, Guang-Nian Zhao, Dong-Mei Ji and Li-Quan Zhou
    Citation: Journal of Ovarian Research 2024 17:99
  26. Ovarian Hyperstimulation Syndrome (OHSS) is a systemic condition marked by the enlargement of the ovaries and heightened vascular permeability. And hypothyroidism (HT) emerges as a potential risk factor for OH...

    Authors: Jing Zhou, Yu Chen, Lijing Bai, Wei Zhou, Haiyan Yang, Yang Chen, Li Chen, Renjie Lu, Lingmin Hu and Shuxian Wang
    Citation: Journal of Ovarian Research 2024 17:98
  27. The epidermal growth factor (EGF)-like factors, comprising amphiregulin (AREG), betacellulin (BTC), and epiregulin (EREG), play a critical role in regulating the ovulatory process. Pentraxin 3 (PTX3), an essen...

    Authors: Yuxi Li, Hsun-Ming Chang, Hua Zhu, Ying-Pu Sun and Peter C. K. Leung
    Citation: Journal of Ovarian Research 2024 17:97
  28. To describe the characteristics of children and adolescents with borderline ovarian tumors (BOTs) and evaluate the efficacy and safety of fertility-sparing surgery (FSS) in these patients.

    Authors: Jiayuan Zhao, Dan Wang, Ruojiao Wang, Yonglan He, Congwei Jia, Lingya Pan, Shuiqing Ma, Ming Wu, Weidi Wang, Xinghan Cheng, Junjun Yang and Yang Xiang
    Citation: Journal of Ovarian Research 2024 17:96
  29. Recent studies have revealed the correlation between serum vitamin D (VD) level and polycystic ovary syndrome (PCOS), but the causality and specific mechanisms remain uncertain.

    Authors: Bingrui Gao, Chenxi Zhang, Deping Wang, Bojuan Li, Zhongyan Shan, Weiping Teng and Jing Li
    Citation: Journal of Ovarian Research 2024 17:95
  30. Genetic studies implicate the oncogenic transcription factor Forkhead Box M1 (FOXM1) as a potential therapeutic target in high-grade serous ovarian cancer (HGSOC). We evaluated the activity of different FOXM1 ...

    Authors: Cassie Liu, Makenzie Vorderbruggen, Catalina Muñoz-Trujillo, Sung Hoon Kim, John A. Katzenellenbogen, Benita S. Katzenellenbogen and Adam R. Karpf
    Citation: Journal of Ovarian Research 2024 17:94
  31. Authors: Yali Fan, Shuya Chen, Chunfang Chu, Xiaodan Yin, Jing Jin, Lingyan Zhang, Huihui Yan, Zheng Cao, Ruixia Liu, Mingwei Xin, Lin Li and Chenghong Yin
    Citation: Journal of Ovarian Research 2024 17:93

    The original article was published in Journal of Ovarian Research 2024 17:67

  32. The present study aimed to elucidate how mesenchymal stem cells (MSCs) application could efficiently attenuate pathological changes of letrozole-induced poly cystic ovary syndrome (PCOS) by modulating mitochon...

    Authors: Arash Abdi, Mina Ranjbaran, Fardin Amidi, Fariba Akhondzadeh and Behjat Seifi
    Citation: Journal of Ovarian Research 2024 17:91
  33. Polycystic Ovary Syndrome (PCOS) is a common reproductive disorder that frequently affects fertility. The TyG-BMI (Triglyceride glucose-body mass) index is a newly explored parameter that may be linked to repr...

    Authors: Xin Li, Ting Luan, Yi Wei, JuanJuan Zhang, Chun Zhao and Xiufeng Ling
    Citation: Journal of Ovarian Research 2024 17:90
  34. Yu Linzhu (YLZ) is a classical Chinese traditional formula, which has been used for more than 600 years to regulate menstruation to help pregnancy. However, the mechanism of modern scientific action of YLZ nee...

    Authors: Xin Ruan, Pengxu Wang, Maolin Wei, Qingqing Yang and Xiaoying Dong
    Citation: Journal of Ovarian Research 2024 17:89
  35. Ovarian cancer (OC) can occur at different ages and is affected by a variety of factors. In order to evaluate the risk of cardiovascular mortality in patients with ovarian cancer, we included influencing facto...

    Authors: Ze-Lin Hu, Ying-Xue Yuan, Meng-Yi Xia, Ying Li, Ying Yang, Sheng-Nan Wang, Xuan-Zhu Meng, Mo-Ying Sun and Ning Wang
    Citation: Journal of Ovarian Research 2024 17:88
  36. Oxidative damage induced granulosa cells (GCs) apoptosis was considered as a significant cause of compromised follicle quality, antioxidants therapy has emerged as a potential method for improving endometriosi...

    Authors: Shishi Li, Yuhang Fan, Chongyi Shu, Yier Zhou and Jing Shu
    Citation: Journal of Ovarian Research 2024 17:87
  37. Target-driven cancer therapy is a notable advancement in precision oncology that has been accompanied by substantial medical accomplishments. Ovarian cancer is a highly frequent neoplasm in women and exhibits ...

    Authors: Anam Beg, Rafat Parveen, Hassan Fouad, M. E. Yahia and Azza S. Hassanein
    Citation: Journal of Ovarian Research 2024 17:86
  38. Omentectomy is an important procedure in surgery for epithelial ovarian cancer, but the scope of omentectomy is not recommended in the guidelines. This study was performed to evaluate the benefits and risks of...

    Authors: Xuhui Dong, Lei Yuan, Ruoyao Zou and Liangqing Yao
    Citation: Journal of Ovarian Research 2024 17:85
  39. Ovarian cancer, among all gynecologic malignancies, exhibits the highest incidence and mortality rate, primarily because it is often presents with non-specific or no symptoms during its early stages. For the a...

    Authors: Priyanka Gautam, Sameer Gupta and Manisha Sachan
    Citation: Journal of Ovarian Research 2024 17:83
  40. To establish a prognostic risk profile for ovarian cancer (OC) patients based on cancer-associated fibroblasts (CAFs) and gain a comprehensive understanding of their role in OC progression, prognosis, and ther...

    Authors: Liang Shen, Aihua Li, Jing Cui, Haixia Liu and Shiqian Zhang
    Citation: Journal of Ovarian Research 2024 17:82
  41. Resveratrol is a natural polyphenolic compound present in plants and red wine with many potential health benefits. This compound has various anti-inflammatory and anti-tumor properties and can improve cellular...

    Authors: A. Conforti, G. G. Iorio, R. Di Girolamo, M. Y. Rovetto, S. Picarelli, F. Cariati, R. Gentile, A. D’Amato, O. Gliozheni, B. Fioretti and C. Alviggi
    Citation: Journal of Ovarian Research 2024 17:81
  42. Chemotherapy exposure has become a main cause of premature ovarian insufficiency (POI). This study aimed to evaluate the role and molecular mechanism of human umbilical cord mesenchymal stem cell-derived exoso...

    Authors: Yuan Zhou, Jinfa Huang, Lingling Zeng, Qian Yang, Fangjuan Bai, Qiqing Mai and Kaixian Deng
    Citation: Journal of Ovarian Research 2024 17:80
  43. IR emerges as a feature in the pathophysiology of PCOS, precipitating ovulatory anomalies and endometrial dysfunctions that contribute to the infertility challenges characteristic of this condition. Despite it...

    Authors: Xi Luo, Yunhua Dong, Haishan Zheng, Xiaoting Zhou, Lujuan Rong, Xiaoping Liu, Yun Bai, Yunxiu Li and Ze Wu
    Citation: Journal of Ovarian Research 2024 17:79
  44. This study investigated the association between Anti-Müllerian Hormone (AMH) and relevant metabolic parameters and assessed its predictive value in the clinical diagnosis of polycystic ovarian syndrome (PCOS).

    Authors: Li Wang, Mengjun Luo, Xiaoyu Yu, Rong Li, Fei Ye, Dongsheng Xiong, Yan Gong, Mingyue Zheng, Weixin Liu and Jiuzhi Zeng
    Citation: Journal of Ovarian Research 2024 17:78
  45. Our explorative study assessed a panel of molecules for their association with epithelial ovarian carcinomas and their prognostic implications. The panel included tissue expression of VEGF-C, COX-2, Ki-67 and ...

    Authors: J. Bhaskari, Rahul Bhagat, V. Shilpa, C.S. Premalata and Lakshmi Krishnamoorthy
    Citation: Journal of Ovarian Research 2024 17:77
  46. Polycystic ovary syndrome (PCOS) is a complex endocrine disorder in women that necessitates effective and safe treatment alternatives. This study aimed to evaluate the therapeutic efficacy of Vitex negundo seed i...

    Authors: Tarun Kumar Kar, Sananda Sil, Angshita Ghosh, Ananya Barman and Sandip Chattopadhyay
    Citation: Journal of Ovarian Research 2024 17:76

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.